2.36
0.15 (6.79%)
| Penutupan Terdahulu | 2.21 |
| Buka | 2.10 |
| Jumlah Dagangan | 12,204,798 |
| Purata Dagangan (3B) | 8,699,820 |
| Modal Pasaran | 712,501,504 |
| Harga / Jualan (P/S) | 4.42 |
| Harga / Buku (P/B) | 18.49 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -1,164.47% |
| EPS Cair (TTM) | -2.74 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -4.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 766.18% |
| Nisbah Semasa (MRQ) | 6.68 |
| Aliran Tunai Operasi (OCF TTM) | -174.43 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 69.19 M |
| Pulangan Atas Aset (ROA TTM) | -31.70% |
| Pulangan Atas Ekuiti (ROE TTM) | -177.61% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Pacific Biosciences of Californ | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | -0.38 |
|
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 9.06% |
| % Dimiliki oleh Institusi | 65.90% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Edmond De Rothschild Holding S.A. | 30 Sep 2025 | 10,675,200 |
| Madrone Advisors, Llc | 30 Sep 2025 | 4,976,089 |
| Point72 (Difc) Ltd | 30 Sep 2025 | 4,270,137 |
| Koss-Olinger Consulting, Llc | 30 Sep 2025 | 3,300,000 |
| Amiral Gestion | 31 Dec 2025 | 2,733,290 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 2.00 (Barclays, -15.25%) | Pegang |
| 2.00 (Piper Sandler, -15.25%) | Pegang | |
| 2.00 (Stephens & Co., -15.25%) | Beli | |
| Median | 2.00 (-15.25%) | |
| Purata | 2.00 (-15.25%) | |
| Jumlah | 1 Beli, 2 Pegang | |
| Harga Purata @ Panggilan | 1.91 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Barclays | 15 Dec 2025 | 2.00 (-15.25%) | Pegang | 2.12 |
| Piper Sandler | 11 Nov 2025 | 2.00 (-15.25%) | Pegang | 1.86 |
| Stephens & Co. | 10 Nov 2025 | 2.00 (-15.25%) | Beli | 1.76 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |